Anti-osteoporosis Effect of Cynaropicrin against Ovariectomy-induced Osteoporosis in Rats

ABSTRACT

Background: Osteoporosis is a progressive bone disease, which is characterized by high bone resorption, and low bone density and mass. Osteoporosis elevates the risk of bone fragility and fracture, which leads to significant morbidity and poor life quality. Objectives: The current study focuses to explore the anti-osteoporosis activity of cynaropicrin against the ovariectomized (OVX)-induced osteoporosis in rats. Materials and Methods: The OVX method was performed on the female rats to induce osteoporosis and then treated with 10 and 20 mg/kg of cynaropicrin, respectively, for 16 weeks. The uterus and femur tissues were excised from rats after the sacrification. The biomechanical properties of femur bones were analyzed to detect the stiffness, maximum load, young modulus, and energy absorption. The levels of acid phosphatase (ACP), bone-gla-protein (BGP), and estradiol (E2) in the serum were analyzed. The status of TNF-α, IL-6, IL-1β, osteoprotegerin (OPG), and receptor activator of nuclear factor-κB ligand (RANKL) was analyzed in the serum samples of experimental rats. The femur tissues were examined by histopathological analysis. Results: The cynaropicrin treatment effectively increased the uterine and femoral weight in the OVX rats. The stiffness, maximum load, young modulus, energy, and femoral length were effectively increased by the cynaropicrin treatment. Cynaropicrin decreased the levels of BGP and ACP and increased the E2 level. The Cr, Ca, and P levels were appreciably increased and TNF-α, IL-6 and IL-1β levels were decreased by cynaropicrin on the OVX rats. The cynaropicrin treatment also increased the OPG and reduced the RANKL in the OVX rats. The histological findings revealed that cynaropicrin improved the femur trabecular bone microarchitecture in the OVX rats. Conclusion: Our findings revealed that cynaropicrin increased the femoral weight and length, restored bone turnover markers and mineral profiles, and decreased inflammatory markers.

KEYWORDS

• Estradiol
• Bone-Gla-Protein
• Ovariectomy
• Bone resorption
• Cynaropicrin

Showing references and in-text citations exactly as published.

Cite this article

• DOI10.1177/09731296221137415Copy

RELATED ARTICLES

Matched on section and article type within this issue of Pharmacogn. Mag..

• Article · VOLUME 19, ISSUE 2In vitro Antioxidant and Anti-inflammatory Effects of Erythroxylum cuneatum Leaf Extract on Oxidized Low-density Lipoprotein-stimulated Human Aortic Endothelial CellsSiti Khadijah Adam, Nitya Shanmugam, Sharlina Mohamad, Shamima Abd Rahman, Mohamad Aris Mohd Moklas · pp. 203–213Original ArticleSame type: Article
• Article · VOLUME 19, ISSUE 2Ethacridine Regulation of JAK/STAT/ERK Signaling Pathway in Colon Cancer Cells SW620: In vitro ApproachHui Zhang, Hui Yang, Wei Wei, Jing Zhao, Annamalai Vijayalakshmi, Minhong Wang · pp. 214–221Original ArticleSame type: Article
• Article · VOLUME 19, ISSUE 2LC-MS/MS-based Targeted Metabolomic Profiling of Aqueous and Hydro-alcoholic Extracts of Pistacia integerrima Linn., Quercus infectoria Olivier and Terminalia chebula RetzAnil Kumar Saini, Laxman Sawant, Sultan Zahiruddin, Dhiraj Shrivastva, Ranjan Mitra, Rajiva Kumar Rai, Sayeed Ahmad · pp. 222–230Original ArticleSame type: Article
• Article · VOLUME 19, ISSUE 2Amelioration of AlCl3-induced Memory Loss in the Rats by an Aqueous Extract of Guduchi, a Medhya RasayanaShrirang B. Jamadagni, Pooja M. Ghadge, Mukul S. Tambe, Marimuthu Srinivasan, Goli Penchala Prasad, Pallavi S. Jamadagni, Shyam Baboo Prasad, Sharad D. Pawar, Arun M. Gurav, Sudesh N. Gaidhani, Y. R. Sanjay Kumar, Narayanam Srikanth · pp. 231–243Original ArticleSame type: Article